189 related articles for article (PubMed ID: 18682601)
1. IL-4 protein expression and basal activation of Erk in vivo in follicular lymphoma.
Calvo KR; Dabir B; Kovach A; Devor C; Bandle R; Bond A; Shih JH; Jaffe ES
Blood; 2008 Nov; 112(9):3818-26. PubMed ID: 18682601
[TBL] [Abstract][Full Text] [Related]
2. Activating STAT6 mutations in follicular lymphoma.
Yildiz M; Li H; Bernard D; Amin NA; Ouillette P; Jones S; Saiya-Cork K; Parkin B; Jacobi K; Shedden K; Wang S; Chang AE; Kaminski MS; Malek SN
Blood; 2015 Jan; 125(4):668-79. PubMed ID: 25428220
[TBL] [Abstract][Full Text] [Related]
3. High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells.
Myklebust JH; Irish JM; Brody J; Czerwinski DK; Houot R; Kohrt HE; Timmerman J; Said J; Green MR; Delabie J; Kolstad A; Alizadeh AA; Levy R
Blood; 2013 Feb; 121(8):1367-76. PubMed ID: 23297127
[TBL] [Abstract][Full Text] [Related]
4. Follicular lymphoma cell niche: identification of a preeminent IL-4-dependent T(FH)-B cell axis.
Pangault C; Amé-Thomas P; Ruminy P; Rossille D; Caron G; Baia M; De Vos J; Roussel M; Monvoisin C; Lamy T; Tilly H; Gaulard P; Tarte K; Fest T
Leukemia; 2010 Dec; 24(12):2080-9. PubMed ID: 20944673
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric evaluation of CD38 expression assists in distinguishing follicular hyperplasia from follicular lymphoma.
Mantei K; Wood BL
Cytometry B Clin Cytom; 2009 Sep; 76(5):315-20. PubMed ID: 19382196
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma.
Gulmann C; Espina V; Petricoin E; Longo DL; Santi M; Knutsen T; Raffeld M; Jaffe ES; Liotta LA; Feldman AL
Clin Cancer Res; 2005 Aug; 11(16):5847-55. PubMed ID: 16115925
[TBL] [Abstract][Full Text] [Related]
7. Follicular lymphoma can be distinguished from benign follicular hyperplasia by flow cytometry using simultaneous staining of cytoplasmic bcl-2 and cell surface CD20.
Cornfield DB; Mitchell DM; Almasri NM; Anderson JB; Ahrens KP; Dooley EO; Braylan RC
Am J Clin Pathol; 2000 Aug; 114(2):258-63. PubMed ID: 10941341
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of cytokines, chemokines and their receptors in follicular lymphoma and reactive follicular hyperplasia: assessment by complementary DNA microarray.
Fujii A; Oshima K; Hamasaki M; Utsunomiya H; Okazaki M; Kagami Y; Seto M; Kikuchi M
Oncol Rep; 2005 May; 13(5):819-24. PubMed ID: 15809744
[TBL] [Abstract][Full Text] [Related]
9. PARP14 is a novel target in STAT6 mutant follicular lymphoma.
Mentz M; Keay W; Strobl CD; Antoniolli M; Adolph L; Heide M; Lechner A; Haebe S; Osterode E; Kridel R; Ziegenhain C; Wange LE; Hildebrand JA; Shree T; Silkenstedt E; Staiger AM; Ott G; Horn H; Szczepanowski M; Richter J; Levy R; Rosenwald A; Enard W; Zimber-Strobl U; von Bergwelt-Baildon M; Hiddemann W; Klapper W; Schmidt-Supprian M; Rudelius M; Bararia D; Passerini V; Weigert O
Leukemia; 2022 Sep; 36(9):2281-2292. PubMed ID: 35851155
[TBL] [Abstract][Full Text] [Related]
10. IL-4 and IL-13 suppress prostaglandins production in human follicular dendritic cells by repressing COX-2 and mPGES-1 expression through JAK1 and STAT6.
Cho W; Kim Y; Jeoung DI; Kim YM; Choe J
Mol Immunol; 2011 Mar; 48(6-7):966-72. PubMed ID: 21277633
[TBL] [Abstract][Full Text] [Related]
11. T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling.
Josefsson SE; Huse K; Kolstad A; Beiske K; Pende D; Steen CB; Inderberg EM; Lingjærde OC; Østenstad B; Smeland EB; Levy R; Irish JM; Myklebust JH
Clin Cancer Res; 2018 Feb; 24(4):870-881. PubMed ID: 29217528
[No Abstract] [Full Text] [Related]
12. Induction of the IL-13 receptor alpha2-chain by IL-4 and IL-13 in human keratinocytes: involvement of STAT6, ERK and p38 MAPK pathways.
David M; Ford D; Bertoglio J; Maizel AL; Pierre J
Oncogene; 2001 Oct; 20(46):6660-8. PubMed ID: 11709700
[TBL] [Abstract][Full Text] [Related]
13. Selective induction of eotaxin release by interleukin-13 or interleukin-4 in human airway smooth muscle cells is synergistic with interleukin-1beta and is mediated by the interleukin-4 receptor alpha-chain.
Hirst SJ; Hallsworth MP; Peng Q; Lee TH
Am J Respir Crit Care Med; 2002 Apr; 165(8):1161-71. PubMed ID: 11956062
[TBL] [Abstract][Full Text] [Related]
14. The Tumor Microenvironment in Follicular Lymphoma: Its Pro-Malignancy Role with Therapeutic Potential.
Watanabe T
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069564
[TBL] [Abstract][Full Text] [Related]
15. [Expression and significance of bcl-2 oncogene protein in follicular lymphoma and lymphoid follicular hyperplasia].
Wang J; Zhang J; Zhao X
Zhonghua Bing Li Xue Za Zhi; 1996 Jun; 25(3):149-51. PubMed ID: 9275668
[TBL] [Abstract][Full Text] [Related]
16. Ras/Erk pathway positively regulates Jak1/STAT6 activity and IL-4 gene expression in Jurkat T cells.
So EY; Oh J; Jang JY; Kim JH; Lee CE
Mol Immunol; 2007 Jul; 44(13):3416-26. PubMed ID: 17433443
[TBL] [Abstract][Full Text] [Related]
17. Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection.
Lee N; Wong CK; Chan PK; Lun SW; Lui G; Wong B; Hui DS; Lam CW; Cockram CS; Choi KW; Yeung AC; Tang JW; Sung JJ
Clin Infect Dis; 2007 Sep; 45(6):723-31. PubMed ID: 17712756
[TBL] [Abstract][Full Text] [Related]
18. Signal transducers and activators of transcription 5a-dependent cross-talk between follicular lymphoma cells and tumor microenvironment characterizes a group of patients with improved outcome after R-CHOP.
Taskinen M; Valo E; Karjalainen-Lindsberg ML; Hautaniemi S; Meri S; Leppä S
Clin Cancer Res; 2010 May; 16(9):2615-23. PubMed ID: 20388848
[TBL] [Abstract][Full Text] [Related]
19. Follicular Lymphoma: The Role of the Tumor Microenvironment in Prognosis.
Sugimoto T; Watanabe T
J Clin Exp Hematop; 2016; 56(1):1-19. PubMed ID: 27334853
[TBL] [Abstract][Full Text] [Related]
20. Bcl-6 expression in reactive follicular hyperplasia, follicular lymphoma, and angioimmunoblastic T-cell lymphoma with hyperplastic germinal centers: heterogeneity of intrafollicular T-cells and their altered distribution in the pathogenesis of angioimmunoblastic T-cell lymphoma.
Ree HJ; Kadin ME; Kikuchi M; Ko YH; Suzumiya J; Go JH
Hum Pathol; 1999 Apr; 30(4):403-11. PubMed ID: 10208461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]